Lv1
70 积分 2022-04-06 加入
Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilitation and systematic immune senescence cascade
1天前
已完结
Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial
2天前
已完结
Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti-Programmed Cell Death-1 in HCC
2天前
已完结
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory
2天前
已完结
PARP inhibition elicits NK cell-associated immune evasion via potentiating HLA-G expression in tumor
2天前
已完结
Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma
2天前
已完结
PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2天前
已完结
Combining STING Agonists with PARP Inhibitors Mounts an NK-Dependent Defense against Therapy-Resistant Breast Cancer
2天前
已完结
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Breast Cancer
2天前
已完结
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy
2天前
已完结
皖公网安备34019202002308
